PDMED Resource Utilisation Questionnaire

Submit Usage
Document Provider:
Emma McIntosh
Developer:
Emma McIntosh & Alastair Gray
Contact Details:
Copyright:
Emma McIntosh & Alastair Gray
Country of Origin:
United Kingdom

Study Completed:
Yes
Year:
2000

DIRUM ID:
29
DIRUM Listing:
10/06/2011

Disease Categories

Neurology

Populations - Age

Age Range: 1 - 100

Populations - Sex

Administration Methods

In person

Instrument Types

Recall questionnaire

Person(s) Completing Instrument

Patient

Settings of Care

Community
GP practice
Residential care

Nature of Intervention

Drug

Items of Resource Being Measured

GP
Community nurse
Practice nurse
Outpatient
Informal carer
Day hospital
Social services
Patient incurred
Physiotherapy
Occupational therapy
Social services day care
State benefits
Other NHS - Language therapist
Other non-NHS - use of alternative practitioner

Other Characterisation Details

Frequency Of Economic Data Collection - 12, 24, 36, 48, 60, 72, 84, 96, 108, 120 months
Maximum Recall Period - 10 to 12 months

Primary References

Web Article: Gray R, A large randomised assessment of the relative cost-effectiveness of different classes of drugs for Parkinson's disease (PD MED). NIHR Health Technology Assessment Programme. Available from: , HTA, http://www.hta.ac.uk/1119

Information on how items for costing were identified

Evidence of content validity since questionnaire content developed from expert panel review and previous pilot. REF: Clarke CE, Furmston A, Morgan E, et al. Pilot randomised controlled trial of occupational therapy to optimise independence in Parkinson’s disease: the PD OT trial. J Neurol Neurosurg Psychiatry 2009;80:976–978.

Clarke C E, Furmston A, Morgan E, et al. , Pilot randomised controlled trial of occupational therapy to optimise independence in Parkinson’s disease: the PD OT trial, J Neurol Neurosurg Psychiatry , 2009, 80, 976–978.

DOI: 10.1136/jnnp.2007.138586

Chrischilles E A, Rubenstein L M, Voelker M D, et al, The health burdens of Parkinson’s disease., Mov Disord , 1998, 13, 406–13.

DOI: 10.1002/mds.870130306

Findley L, Aujla M, Bain P G, et al. , Direct economic impact of Parkinson’s disease: a research survey in the United Kingdom., Mov Disord , 2003, 18, 1139–45.

DOI: 10.1002/mds.870130306


Piloting of questionnaires for patient / carer completion

Evidence of content validity since questionnaire content developed from expert panel review and previous pilot. REF: Clarke CE, Furmston A, Morgan E, et al. Pilot randomised controlled trial of occupational therapy to optimise independence in Parkinson’s disease: the PD OT trial. J Neurol Neurosurg Psychiatry 2009;80:976–978.

Clarke C E, Furmston A, Morgan E, et al. , Pilot randomised controlled trial of occupational therapy to optimise independence in Parkinson’s disease: the PD OT trial, J Neurol Neurosurg Psychiatry , 2009, 80, 976–978.

DOI: 10.1136/jnnp.2007.138586


Validation

Evidence of content validity since questionnaire content developed from expert panel review and previous pilot. REF: Clarke CE, Furmston A, Morgan E, et al. Pilot randomised controlled trial of occupational therapy to optimise independence in Parkinson’s disease: the PD OT trial. J Neurol Neurosurg Psychiatry 2009;80:976–978.

Clarke C E, Furmston A, Morgan E, et al. , Pilot randomised controlled trial of occupational therapy to optimise independence in Parkinson’s disease: the PD OT trial, J Neurol Neurosurg Psychiatry , 2009, 80, 976–978.

DOI: 10.1136/jnnp.2007.138586


Instrument Resource


Conditions of Use

  • Free access

The site uses cookies, some may have been set already. Please refer to our privacy policy & cookie usage statement.
If you continue to use the site we'll assume you're happy to accept the cookies.